Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 4/20 | 0.43 |
| ▸ | ADRA2B | P18089 | 4/20 | 0.43 |
| ▸ | ADRA2C | P18825 | 4/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.43 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.43 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29450615 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP1A2CYP2C9CYP2C19ADRA2A | |
| SCHEMBL1330646 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP1A2CYP2C9CYP2C19ADRA2A | |
| SCHEMBL29648886 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP1A2CYP2C9CYP2C19ADRA2A | |
| SCHEMBL29450632 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP1A2CYP2C9CYP2C19ADRA2A | |
| SCHEMBL547207 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP1A2CYP2C9CYP2C19ADRA2A | |
| SCHEMBL7532913 | 0.92 | MIF (0.45) | ALDH1A1CYP1A2CYP2C9CYP2C19ADRA2A | |
| SCHEMBL7532922 | 0.92 | MIF (0.45) | ALDH1A1CYP1A2CYP2C9CYP2C19ADRA2A | |
| SCHEMBL331134 | 0.82 | MIF (0.39) | ALDH1A1CYP1A2LMNA | |
| SCHEMBL8850662 | 0.82 | AKR1B1 (0.35) | ADRA2AADRA2BADRA2CADRA1AADRA1D | |
| SCHEMBL3886974 | 0.82 | MIF (0.52) | ALDH1A1CYP1A2CYP2C9CYP2C19ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 638 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11760750-B1 | Process for preparing levoketoconazole | NURAY CHEMICALS PRIVATE LIMITED (IN) | 2023-09-19 | — | — | US | claimed |
| US-20230151136-A1 | CATALYST COMPOSITION FOR POLYURETHANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-05-18 | — | — | US | claimed |
| US-20230134280-A1 | CATALYSTS FOR THE FORMATION OF POLYURETHANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-05-04 | — | — | US | claimed |
| EP-4114877-A1 | CATALYSTS FOR THE FORMATION OF POLYURETHANES | Momentive Performance Materials Inc. (US) | 2023-01-11 | — | — | EP | claimed |
| EP-4114566-A1 | CATALYST COMPOSITION FOR POLYURETHANES | Momentive Performance Materials Inc. (US) | 2023-01-11 | — | — | EP | claimed |
| US-20210332211-A1 | CATALYSTS FOR PRODUCING POLYURETHANES | MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) | 2021-10-28 | — | — | US | claimed |
| EP-3612581-B1 | CATALYSTS FOR PRODUCING POLYURETHANES | MOMENTIVE PERFORMANCE MAT GMBH (DE) | 2020-12-23 | — | — | EP | claimed |
| EP-3612581-A1 | CATALYSTS FOR PRODUCING POLYURETHANES | Momentive Performance Materials GmbH (DE) | 2020-02-26 | — | — | EP | claimed |
| WO-2020011343-A1 | CATALYSTS FOR PRODUCING POLYURETHANES | MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) | 2020-01-16 | — | — | WO | claimed |
| EP-2170805-A2 | METHODS OF SYNTHESIZING CINACALCET AND SALTS THEREOF | Amgen Inc. (US) | 2010-04-07 | — | — | EP | claimed |
| US-20040167249-A1 | Phase change inks with isocyanate-derived antioxidants and UV stabilizers | XEROX CORPORATION | 2004-08-26 | — | — | US | claimed |
| US-6764541-B1 | Colorant compositions | XEROX CORPORATION | 2004-07-20 | — | — | US | claimed |
| US-6652635-B2 | Cyan phase change inks | XEROX CORPORATION | 2003-11-25 | — | — | US | claimed |
| US-20030079645-A1 | Cyan phase change inks | XEROX CORPORATION | 2003-05-01 | — | — | US | claimed |
| EP-0566567-B1 | ANTIHYPERTENSIVE BENZOPYRAN DERIVATIVES | AMERICAN HOME PROD (US) | 1997-11-19 | — | — | EP | claimed |
| EP-0566567-A1 | ANTIHYPERTENSIVE BENZOPYRAN DERIVATIVES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1993-10-27 | — | — | EP | claimed |
| EP-0314446-B1 | NOVEL ANTIHYPERTENSIVE BENZOPYRAN DERIVATIVES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1993-09-15 | — | — | EP | claimed |
| WO-1992012153-A1 | NOVEL ANTIHYPERTENSIVE BENZOPYRAN DERIVATIVES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1992-07-23 | — | — | WO | claimed |
| EP-0314446-A2 | Novel antihypertensive benzopyran derivatives | AMERICAN HOME PRODUCTS CORPORATION (US) | 1989-05-03 | — | — | EP | claimed |
| US-4463176-A | REGENERATION OF SEPARATED CHIRAL ISOCYANATE-TREATED ADRENERGIC BLOCKING AGENTS USING HYDRAZINE HYDRATE AND A KETO ACID | MEAD JOHNSON & COMPANY (US) | 1984-07-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11760750-B1 | Process for preparing levoketoconazole | KHK, KYAT3, PLK3 | ALDH1A1 2659/4885CYP1A2 209/4885CYP2C9 108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.